CRISPR Reagents

EPHA3 Gene Knockout Kit (Human)

Knockout any human or mouse protein-coding gene with XDel technology.

Bulk Upload
Need a quote? Add to cart and download one instantly at checkout — to reference on a purchase order, submit for budget approval, or keep for your records. No need to contact sales.

ENSG00000044524
This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. This gene encodes a protein that binds ephrin-A ligands. Two alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Jul 2008]
Molecular Function8
Biological Process17
Cellular Component5

Common questions about the EPHA3 knockout kit

How many guides does the EPHA3 knockout kit use?
The kit's XDel design targets EPHA3 with 3 guides, and the earliest cut is in exon 3 of its canonical transcript.
Which EPHA3 transcripts does the knockout cut?
The XDel guides cut 10 EPHA3 transcripts, including the canonical transcript ENST00000336596. They cut all 4 of its CCDS protein-coding transcripts.
Do the EPHA3 guides cut other genes?
No. Our design analysis predicts no off-target potential in any other gene for these guides.
Gene Knockout Kits Provide Superior Editing Efficiency in iPSC, Immortalized, and Primary Cells and Consistent Protein Depletion Using the XDel Design
XDel is a cutting-edge CRISPR knockout technology designed to remove the guesswork from gene editing. By leveraging an innovative guide RNA design strategy, XDel delivers highly efficient, consistent, and reproducible gene knockouts—empowering researchers to accelerate their discoveries with confidence.